Sep. 25, 2024 — Almost everyone knows about HIV. Fewer people know about its relative, HTLV-1. However, HTLV-1 can cause serious illnesses, including cancer. To develop ways to combat this virus ...

LifeMD (LFMD) announces the launch by its Rex MD men’s health brand of TestoRx, a new direct-to-consumer men’s hormone ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine months ended September 30, 2024 after the close ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces the launch by its Rex MD men’s health brand of TestoRx, a new direct-to-consumer men’s hormone therapy ...

PharmaTher Holdings Ltd. (the "Company” or "PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has issued a ...

Buy and Sell Signals for Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock LFMDP that help investors manage ...

Analyst David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD – Research Report) and keeping the price target at $12.00. David ...

Key Insights Significant control over LifeMD by retail investors implies that the general public has more power ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 20.85% ...

Revised Full-Year Adjusted EBITDA Guidance: $13 million to $15 million, down from $18 million to $22 million. LifeMD Inc (NASDAQ:LFMD) reported a 67% year-over-year revenue growth in its core ...